Literature DB >> 33717116

Phenotype Definition for "Resisters" to Mycobacterium tuberculosis Infection in the Literature-A Review and Recommendations.

Jesús Gutierrez1, Elouise E Kroon2, Marlo Möller2, Catherine M Stein1.   

Abstract

Tuberculosis (TB) remains a worldwide problem. Despite the high disease rate, not all who are infected with Mycobacterium Tuberculosis (Mtb) develop disease. Interferon-γ (IFN-γ) specific T cell immune assays such as Quantiferon and Elispot, as well as a skin hypersensitivity test, known as a tuberculin skin test, are widely used to infer infection. These assays measure immune conversion in response to Mtb. Some individuals measure persistently negative to immune conversion, despite high and prolonged exposure to Mtb. Increasing interest into this phenotype has led to multiple publications describing various aspects of these responses. However, there is a lack of a unified "resister" definition. A universal definition will improve cross study data comparisons and assist with future study design and planning. We review the current literature describing this phenotype and make recommendations for future studies.
Copyright © 2021 Gutierrez, Kroon, Möller and Stein.

Entities:  

Keywords:  interferon-γ release assay; phenotype; resister; review; tuberculin skin test; tuberculosis

Mesh:

Year:  2021        PMID: 33717116      PMCID: PMC7946835          DOI: 10.3389/fimmu.2021.619988

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  85 in total

Review 1.  Human immunodeficiency virus associated tuberculosis more often due to recent infection than reactivation of latent infection.

Authors:  R M G J Houben; A C Crampin; R Ndhlovu; P Sonnenberg; P Godfrey-Faussett; W H Haas; G Engelmann; C J Lombard; D Wilkinson; J Bruchfeld; S Lockman; J Tappero; J R Glynn
Journal:  Int J Tuberc Lung Dis       Date:  2011-01       Impact factor: 2.373

2.  Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of Mycobacterium tuberculosis Infection.

Authors:  Elisa Nemes; Virginie Rozot; Hennie Geldenhuys; Nicole Bilek; Simbarashe Mabwe; Deborah Abrahams; Lebohang Makhethe; Mzwandile Erasmus; Alana Keyser; Asma Toefy; Yolundi Cloete; Frances Ratangee; Thomas Blauenfeldt; Morten Ruhwald; Gerhard Walzl; Bronwyn Smith; Andre G Loxton; Willem A Hanekom; Jason R Andrews; Maria D Lempicki; Ruth Ellis; Ann M Ginsberg; Mark Hatherill; Thomas J Scriba
Journal:  Am J Respir Crit Care Med       Date:  2017-09-01       Impact factor: 21.405

Review 3.  Fourth-Generation QuantiFERON-TB Gold Plus: What Is the Evidence?

Authors:  Arena Shafeque; Jacob Bigio; Catherine A Hogan; Madhukar Pai; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

4.  Equal sensitivity of the new generation QuantiFERON-TB Gold plus in direct comparison with the previous test version QuantiFERON-TB Gold IT.

Authors:  H Hoffmann; K Avsar; R Göres; S-C Mavi; S Hofmann-Thiel
Journal:  Clin Microbiol Infect       Date:  2016-05-13       Impact factor: 8.067

5.  A Functional Role for Antibodies in Tuberculosis.

Authors:  Lenette L Lu; Amy W Chung; Tracy R Rosebrock; Musie Ghebremichael; Wen Han Yu; Patricia S Grace; Matthew K Schoen; Fikadu Tafesse; Constance Martin; Vivian Leung; Alison E Mahan; Magdalena Sips; Manu P Kumar; Jacquelynne Tedesco; Hannah Robinson; Elizabeth Tkachenko; Monia Draghi; Katherine J Freedberg; Hendrik Streeck; Todd J Suscovich; Douglas A Lauffenburger; Blanca I Restrepo; Cheryl Day; Sarah M Fortune; Galit Alter
Journal:  Cell       Date:  2016-09-22       Impact factor: 41.582

6.  Changing prevalence of tuberculosis infection with increasing age in high-burden townships in South Africa.

Authors:  R Wood; H Liang; H Wu; K Middelkoop; T Oni; M X Rangaka; R J Wilkinson; L-G Bekker; S D Lawn
Journal:  Int J Tuberc Lung Dis       Date:  2010-04       Impact factor: 2.373

7.  Major Loci on Chromosomes 8q and 3q Control Interferon γ Production Triggered by Bacillus Calmette-Guerin and 6-kDa Early Secretory Antigen Target, Respectively, in Various Populations.

Authors:  Fabienne Jabot-Hanin; Aurélie Cobat; Jacqueline Feinberg; Ghislain Grange; Natascha Remus; Christine Poirier; Anne Boland-Auge; Céline Besse; Jacinta Bustamante; Stéphanie Boisson-Dupuis; Jean-Laurent Casanova; Erwin Schurr; Alexandre Alcaïs; Eileen G Hoal; Christophe Delacourt; Laurent Abel
Journal:  J Infect Dis       Date:  2015-12-21       Impact factor: 5.226

Review 8.  Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection.

Authors:  Jason D Simmons; Catherine M Stein; Chetan Seshadri; Monica Campo; Galit Alter; Sarah Fortune; Erwin Schurr; Robert S Wallis; Gavin Churchyard; Harriet Mayanja-Kizza; W Henry Boom; Thomas R Hawn
Journal:  Nat Rev Immunol       Date:  2018-09       Impact factor: 108.555

9.  Global variation in bacterial strains that cause tuberculosis disease: a systematic review and meta-analysis.

Authors:  Kirsten E Wiens; Lauren P Woyczynski; Jorge R Ledesma; Jennifer M Ross; Roberto Zenteno-Cuevas; Amador Goodridge; Irfan Ullah; Barun Mathema; Joel Fleury Djoba Siawaya; Molly H Biehl; Sarah E Ray; Natalia V Bhattacharjee; Nathaniel J Henry; Robert C Reiner; Hmwe H Kyu; Christopher J L Murray; Simon I Hay
Journal:  BMC Med       Date:  2018-10-30       Impact factor: 8.775

10.  Fine-mapping analysis of a chromosome 2 region linked to resistance to Mycobacterium tuberculosis infection in Uganda reveals potential regulatory variants.

Authors:  Robert P Igo; Noémi B Hall; LaShaunda L Malone; Jacob B Hall; Barbara Truitt; Feiyou Qiu; Li Tao; Ezekiel Mupere; Audrey Schnell; Thomas R Hawn; William S Bush; Moses Joloba; W Henry Boom; Catherine M Stein
Journal:  Genes Immun       Date:  2018-08-13       Impact factor: 2.676

View more
  1 in total

1.  Monocyte Transcriptional Responses to Mycobacterium tuberculosis Associate with Resistance to Tuberculin Skin Test and Interferon Gamma Release Assay Conversion.

Authors:  Jason D Simmons; Kimberly A Dill-McFarland; Catherine M Stein; Phu T Van; Violet Chihota; Thobani Ntshiqa; Pholo Maenetje; Glenna J Peterson; Penelope Benchek; Mary Nsereko; Kavindhran Velen; Katherine L Fielding; Alison D Grant; Raphael Gottardo; Harriet Mayanja-Kizza; Robert S Wallis; Gavin Churchyard; W Henry Boom; Thomas R Hawn
Journal:  mSphere       Date:  2022-06-13       Impact factor: 5.029

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.